Potential impact of seasonal forcing on a SARS-CoV-2 pandemic.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
09 03 2020
Historique:
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 20 3 2020
Statut: epublish

Résumé

A novel coronavirus (SARS-CoV-2) first detected in Wuhan, China, has spread rapidly since December 2019, causing more than 100,000 confirmed infections and 4000 fatalities (as of 10 March 2020). The outbreak has been declared a pandemic by the WHO on Mar 11, 2020. Here, we explore how seasonal variation in transmissibility could modulate a SARS-CoV-2 pandemic. Data from routine diagnostics show a strong and consistent seasonal variation of the four endemic coronaviruses (229E, HKU1, NL63, OC43) and we parameterise our model for SARS-CoV-2 using these data. The model allows for many subpopulations of different size with variable parameters. Simulations of different scenarios show that plausible parameters result in a small peak in early 2020 in temperate regions of the Northern Hemisphere and a larger peak in winter 2020/2021. Variation in transmission and migration rates can result in substantial variation in prevalence between regions. While the uncertainty in parameters is large, the scenarios we explore show that transient reductions in the incidence rate might be due to a combination of seasonal variation and infection control efforts but do not necessarily mean the epidemic is contained. Seasonal forcing on SARS-CoV-2 should thus be taken into account in the further monitoring of the global transmission. The likely aggregated effect of seasonal variation, infection control measures, and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.

Identifiants

pubmed: 32176808
doi: 10.4414/smw.2020.20224
pii: Swiss Med Wkly. 2020;150:w20224
doi:
pii:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20224

Auteurs

Richard A Neher (RA)

Biozentrum, University of Basel, Basel, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Robert Dyrdak (R)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden / Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.

Valentin Druelle (V)

Biozentrum, University of Basel, Basel, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Emma B Hodcroft (EB)

Biozentrum, University of Basel, Basel, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Jan Albert (J)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden / Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH